Literature DB >> 8703445

Loss of protective immunity to polio, diphtheria and Haemophilus influenzae type b after allogeneic bone marrow transplantation.

T Parkkali1, T Ruutu, M Stenvik, T Kuronen, H Käyhty, T Hovi, R M Olander, L Volin, P Ruutu.   

Abstract

Immunity to poliovirus, diphtheria and Haemophilus influenzae type b (Hib) was studied in 16 adult recipients of a bone marrow transplant from an HLA-identical sibling donor in order to evaluate the need for revaccinations. T-cell depletion was not done in any case. The donors and patients were studied before bone marrow transplantation (BMT) and the patients 1, 3, 6, and 12 months later. Prior to the BMT 10 of 11 patients were immune (titre > or = 4) to all vaccine poliovirus types by a standard microneutralization assay. At 12 months after BMT only two of seven patients were immune to all vaccine types, and none had immunity against an antigenically altered poliovirus type 3 strain Finland. The geometric means of antibody titres against poliovirus types 1, 2, and 3 strain Saukett and strain Finland declined gradually after 1 month postgrafting, being 4.4, 5.4, 3.3, and 1.3 respectively at 12 months after BMT. At 1 year 6 of 11 patients had immunity against diphtheria by a toxin neutralization method, but the antitoxin geometric mean level had decreased to a barely protective level, 0.01 IU/ml. The geometric mean Hib antibody concentration decreased during the first 6 months after BMT and thereafter increased slightly. A significant proportion of BMT recipients lose their protection against polio, diphtheria and Hib, and revaccinations are necessary.

Entities:  

Mesh:

Year:  1996        PMID: 8703445

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  9 in total

1.  Immunization for bone marrow transplant recipients.

Authors:  B Lynn Johnston; John M Conly
Journal:  Can J Infect Dis       Date:  2002-11

Review 2.  Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection.

Authors:  Rohtesh S Mehta; Katayoun Rezvani
Journal:  Virulence       Date:  2016-07-06       Impact factor: 5.882

Review 3.  B cells and transplantation: an educational resource.

Authors:  Trudy N Small; William H Robinson; David B Miklos
Journal:  Biol Blood Marrow Transplant       Date:  2009-01       Impact factor: 5.742

4.  Persistence of Yellow Fever vaccine-induced antibodies after cord blood stem cell transplant.

Authors:  Vivian Iida Avelino-Silva; Marcos da Silva Freire; Vanderson Rocha; Celso Arrais Rodrigues; Yana Sarkis Novis; Ester C Sabino; Esper Georges Kallas
Journal:  Hum Vaccin Immunother       Date:  2015-11-30       Impact factor: 3.452

Review 5.  B Cell Reconstitution and Influencing Factors After Hematopoietic Stem Cell Transplantation in Children.

Authors:  Nicolaas G van der Maas; Dagmar Berghuis; Mirjam van der Burg; Arjan C Lankester
Journal:  Front Immunol       Date:  2019-04-12       Impact factor: 7.561

6.  Immune Status Against Hepatitis B in Patients After Allogeneic Hematopoietic Cell Transplantation-Factors Affecting Early and Long-Lasting Maintenance of Protective Anti-HBs Titers.

Authors:  Agnieszka Piekarska; Piotr Wisniewski; Krzysztof Lewandowski; Lidia Gil; Piotr Trzonkowski; Maria Bieniaszewska; Jan Maciej Zaucha
Journal:  Front Immunol       Date:  2020-11-24       Impact factor: 7.561

7.  Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.

Authors:  Andrew J Ullmann; Martin Schmidt-Hieber; Hartmut Bertz; Werner J Heinz; Michael Kiehl; William Krüger; Sabine Mousset; Stefan Neuburger; Silke Neumann; Olaf Penack; Gerda Silling; Jörg Janne Vehreschild; Hermann Einsele; Georg Maschmeyer
Journal:  Ann Hematol       Date:  2016-06-24       Impact factor: 3.673

8.  Measuring the cellular memory B cell response after vaccination in patients after allogeneic stem cell transplantation.

Authors:  Julia Winkler; Hannes Tittlbach; Andrea Schneider; Corinna Buchstaller; Andreas Mayr; Ingrid Vasova; Wolf Roesler; Michael Mach; Andreas Mackensen; Thomas H Winkler
Journal:  Ann Hematol       Date:  2020-06-09       Impact factor: 3.673

Review 9.  Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network.

Authors:  Heinz Ludwig; Mario Boccadoro; Philippe Moreau; Jesus San-Miguel; Michele Cavo; Charlotte Pawlyn; Sonja Zweegman; Thierry Facon; Christoph Driessen; Roman Hajek; Melitios A Dimopoulos; Francesca Gay; Hervé Avet-Loiseau; Evangelos Terpos; Niklas Zojer; Mohamad Mohty; Maria-Victoria Mateos; Hermann Einsele; Michel Delforge; Jo Caers; Katja Weisel; Graham Jackson; Laurent Garderet; Monika Engelhardt; Niels van de Donk; Xavier Leleu; Hartmut Goldschmidt; Meral Beksac; Inger Nijhof; Niels Abildgaard; Sara Bringhen; Pieter Sonneveld
Journal:  Leukemia       Date:  2020-08-19       Impact factor: 11.528

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.